Source: Annual Congress 2013 –Quality management in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Farley, J. Maclay, C. Tweed, P. Carroll, R. Milroy (Glasgow, United Kingdom). Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival. Eur Respir J 2013; 42: Suppl. 57, 4827

Member's Comments

No comment yet.

Related content which might interest you: The impact of HIV infection on the presentation and prognosis of lung cancer Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Reducing delays in lung cancer diagnostic pathways to improve patient experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Mode of influence of the type of the chest wall invasion to the outcome of surgical treatment of patients with primary lung cancer Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Defining a standard set of patient-centered outcomes for patients with lung cancer Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Does bronchial location of lung cancer influence overall survival? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Revisiting lung function measurements before lung cancer surgery Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 The prognostic value of the tumor shrinkage rate for progression-free survival in patients with non-small cell lung cancer receiving gefitinib Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Is there a difference in response to first line chemotherapy related to age in patients with locally advanced or metastatic non-small lung cancer? Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014